Table 3.
Effect of RAP on Fn, FHC, and FLC protein expression in rats with CIRI induced by MCAO.
| Group | Fn | FHC | FLC |
|---|---|---|---|
| Sham | 52.238 ± 4.77 | 0.481 ± 0.07 | 0.620 ± 0.04 |
| Model | 79.32 ± 4.94∗∗ | 0.933 ± 0.04∗∗ | 0.938 ± 0.04∗∗ |
| RAP granule (2.5 g/kg/d) | 44.766 ± 6.42## | 0.575 ± 0.07## | 0.475 ± 0.09## |
| RAP injection (2 ml/kg/d) | 52.086 ± 4.86## | 0.465 ± 0.11## | 0.668 ± 0.09# |
| Calycosin (10 mg/kg/d) | 55.802 ± 3.18# | 0.703 ± 0.08# | 0.607 ± 0.08## |
| Edaravone (6.3 mg/kg/d) | 69.564 ± 7.00 | 0.562 ± 0.08## | 0.612 ± 0.07## |
| Deferoxamine (70 mg/kg/d) | 54.046 ± 8.96## | 0.523 ± 0.06## | 0.505 ± 0.06## |
Data are expressed as the mean ± SEM, n = 5. ∗∗P < 0.01 vs. sham group. #P < 0.05 and ##P < 0.01 vs. model group.